$0.000001
At close: Mar 5, 10:22 AM EDT
Comments
Loading...
Biocept Analyst Ratings and Price Targets | OTC:BIOCQ | Benzinga
Biocept Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Biocept Corp from these most-recent analyst ratings.
Analyst Ratings for Biocept
Data brought to you by Benzinga APIs
FAQ
What is the target price for Biocept (BIOCQ) stock?
There is no price target for Biocept
What is the most recent analyst rating for Biocept (BIOCQ)?
There is no analyst for Biocept
When was the last upgrade for Biocept (BIOCQ)?
There is no last upgrade for Biocept
When was the last downgrade for Biocept (BIOCQ)?
There is no last downgrade for Biocept.
When is the next analyst rating going to be posted or updated for Biocept (BIOCQ)?
There is no next analyst rating for Biocept.
Is the Analyst Rating Biocept (BIOCQ) correct?
There is no next analyst rating for Biocept.
Browse analyst ratings and price targets on all stocks.